Children 2 and 3 years old who have wheezing, asthma and/or allergies or an immediate family member who has these conditions may be eligible to participate.
This study includes study visits over 4 years.
Your child will be randomized – assigned a study group by chance, like flipping a coin – into one of two study groups. One group will take Xolair™, and the other group will take placebo (inactive fake medication).
The study is conducted in three parts:
All children in the study will be given standard medications and managed by the study doctor for the treatment of breathing symptoms, such as wheezing and cough during the study period.
Parents or guardians interested in having their child participate will be given a consent form that thoroughly explains all of the details of the study. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered.
Being in this study may not help your child right now. However, he/she will receive allergy and lung tests and frequent monitoring, education and treatment for breathing problems which may help with their health.
Overall, when we complete this study, we hope that we will know more about the study medication Xolair™. This could help children with asthma in the future.
Participants will receive health exams and breathing evaluations at no charge and compensation for time and travel.